CRS: Whitman-Walker
Position: Pharmacist of Record
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
